.80% institutional ownership Mr Rosenberg as you should well know FSD pharma is majority owned by retail investors much like yourself. The retail investors you reference who buy small amounts of shares (which you claim does not influence or impact the stock price) once had this company setting trading volume records at one point in time. The company has what they have due mostly in part to retail investment , not institutional. How can you make such statements when this company has been built off the backs of retail investors such as yourself ? You are clearly in over your head here imo. https://www.nasdaq.com/market-activity/stocks/huge/institutional-holdings